LOGIN
Aspirin vs. Enoxaparin for Preventing Symptomatic Venous Thromboembolism in Hip or Knee Arthroplasty
January 2023
Aspirin vs. Enoxaparin for Preventing Symptomatic Venous Thromboembolism in Hip or Knee Arthroplasty
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1
Effect of Aspirin vs Enoxaparin on Symptomatic Venous Thromboembolism in Patients Undergoing Hip or Knee Arthroplasty: The CRISTAL Randomized Trial
JAMA. 2022 Aug 23;328(8):719-727.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
9711 patients with osteoarthritis undergoing a hip or knee arthroplasty procedure at one of 31 participating hospitals were randomized (in this hospital-level, cluster-randomized, crossover, non-inferiority trial) to receive aspirin (n=5675) or enoxaparin (n=4036) for the prevention of symptomatic venous thromboembolism (VTE). The primary outcome of interest was symptomatic VTE within 90 days, inc...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.